FABP2 and Cirrhosis: One study that examined translocated microbial products and their ability to predict cirrhosis and progression to end-stage liver disease in HCV and HBV infection found elevated plasma levels of LPS, IFABP, IL-6, and sCD14 in patients with HCV or HBV compared to uninfected controls [3].